Press release

Siemens Healthineers Exhibits Solutions That Drive Outcomes That Matter to Healthcare Providers and Patients

Sponsored by Businesswire

There are more than 7.5 billion people on Earth1—and each one
is deserving of accurate diagnostic test results. Each healthcare
institution faces unique challenges to deliver results quickly and
efficiently, which is why Siemens Healthineers is focusing clinical
chemistry and laboratory medicine professionals’ attention on its Outcomes
that Matter
exhibit (Booth #51) at the 23rd IFCC-EFLM European
Congress of Clinical Chemistry and Laboratory Medicine.

“Whether laboratories need the highest immunoassay testing throughput, a
true high-sensitivity troponin I assay for cardiac testing, a handheld
blood gas analyzer that can deliver results in less than one minute, one
of the largest ranges of molecular assays for infectious disease
testing, or artificial intelligence to drive adaptive, enhanced
performance, Siemens Healthineers offers proven, customized diagnostic
solutions that are transforming care delivery,” said Michael Reitermann,
Member of the Managing Board and President, Diagnostics, Siemens
Healthineers. “We invite attendees to see all these offerings firsthand
in our booth.”

Siemens Healthineers will showcase in Booth #51 new innovations for
laboratory, point-of-care and molecular testing. In addition to hands-on
product demonstrations, visitors to the Siemens Healthineers booth can
choose their own virtual reality journey through a simulated hospital
environment to visualize in vitro testing and workflow possibilities
based upon their needs.

On display will be an integrated suite of sample management
configurations that expand the power of the Atellica®
Solution, including a decapper, an enhanced vision system, a sealer, and
customized sorting options.2 A tablet-based easy-to-navigate
tile-based virtual assistant helps laboratories to improve workflow by
simplifying and organizing operator interactions in a unique software
solution. Siemens Healthineers also will demonstrate its offerings for
clinical excellence including a broad and differentiated assay menu,
diagnostics IT applications that help laboratories stay at the forefront
of industry innovations, and AI-powered predictive maintenance
capabilities for the instruments.

Attendees can see firsthand the newest innovation in blood gas for
point-of-care testing, which will be unveiled at the show. The RAPIDPoint®
500e Blood Gas System2 is designed to offer an improved user
experience and set an elevated standard in simplicity, quality, and data
security for healthcare organizations. For laboratories interested in
expanding their molecular diagnostic offerings, the new Fast Track
Diagnostics testing menu from Siemens Healthineers features syndromic
panels to improve patient care delivery, platform-agnostic kits for
increased customer flexibility, and new lyophilized assays for improved

In addition to its booth offerings, Siemens Healthineers is sponsoring
educational workshops on industry hot topics such as high-sensitivity
cardiac troponin I, the implementation of the Atellica Solution, the
evolving role of biomarkers in prenatal care, and the implementation of
point-of-care testing for effective patient management. To learn more
about these presentations, please visit



Under development. Not commercially available. Future availability
cannot be guaranteed.


Fast Track Diagnostics assays are CE-marked for IVD use in the EU
The AtellicaSolution’s immunoassay analyzer can run up to 440 tests
per hour—the industry’s highest productivity per square
meter—depending on test mix.

Siemens Healthineers enables healthcare providers worldwide to
increase value by empowering them on their journey towards expanding
precision medicine, transforming care delivery, improving patient
experience and digitalizing healthcare. A leader in medical technology,
Siemens Healthineers is constantly innovating its portfolio of products
and services in its core areas of diagnostic and therapeutic imaging and
in laboratory diagnostics and molecular medicine. Siemens Healthineers
is also actively developing its digital health services and enterprise
services. In fiscal 2018, which ended on September 30, 2018, Siemens
Healthineers generated revenue of €13.4 billion and adjusted profit of
€2.3 billion and has about 50,000 employees worldwide. Further
information is available at